Elevation Wealth Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46.9K Buy
110
+54
+96% +$22.1K 0.01% 411
2026
Q2
$21.8K Buy
56
+38
+211% +$16.1K 0.01% 564
2026
Q1
$8.52K Buy
18
+1
+6% +$503 ﹤0.01% 556
2025
Q4
$7.94K Buy
17
+7
+70% +$3.25K ﹤0.01% 528
2025
Q3
$4.26K Buy
+10
New +$3.88K ﹤0.01% 509
2024
Q2
– Sell
-40
Closed -$13.3K – 523
2024
Q1
$13.3K Hold
40
– – 0.01% 333
2023
Q4
$9.84K Buy
+40
New +$9.89K 0.01% 332

Other funds holding HCA

Elevation Wealth Partners's HCA Position: Q3 2026 in Review

Elevation Wealth Partners increased its HCA Healthcare (HCA) stake by 96% in Q3 2026, buying an estimated $22.1K and bringing the position to 110 shares worth $46.9K. The position accounts for 0.01% of the portfolio, ranked #411.

Elevation Wealth Partners first reported a position in HCA in Q4 2023 and has held it in 7 quarters since. 55 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Elevation Wealth Partners held 110 shares of HCA Healthcare worth $46.9K as of Q3 2026.
  • Elevation Wealth Partners bought 54 HCA Healthcare shares in Q3 2026, an estimated $22.1K.
  • HCA Healthcare made up 0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #411 holding.
  • Elevation Wealth Partners first reported a position in HCA Healthcare in Q4 2023 and has held it in 7 quarters since.
  • 55 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.